olumacostat glasaretil
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
5
Phase 3
3
Phase 4
0
Earliest trial started Aug 1, 2013 (NCT01936324)
Timeline
Indications
Studied for
Mechanism of action
- Acetyl-CoA carboxylase 1INHIBITOR
ACACA inhibitor
- Acetyl-CoA carboxylaseINHIBITOR
Acetyl-CoA carboxylase inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
CCCCCCCCCCCCCCOc1ccc(C(=O)OCC(=O)N(C)CC(=O)OCC)o1- Mol. weight
- 481.63 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Prodrug
Sources
- ChEMBLCHEMBL3989947 ↗
Also known as
- drm01
- drm01b
- drm01b
- olumacostat glasaretil
- olumacostat glasaretil
- olumacostat glasaretil
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03127956 | Phase 3 | Mar 21, 2017 | Dermira, Inc. |
| NCT03073486 | Phase 3 | Feb 6, 2017 | Dermira, Inc. |
| NCT03028363 | Phase 3 | Dec 27, 2016 | Dermira, Inc. |
| NCT02431052 | Phase 2 | Apr 1, 2015 | Dermira, Inc. |
| NCT01936324 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2013 | Dermira, Inc. |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Dermira, Inc. | For profit | 5 | 5 | 2 | 2013 |
1 organizations
Page 1 / 1